Related Experiment Video
Updated: May 15, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Obesity in pregnancy. Part 1: prevalence and risks
The Practising Midwife
|December 21, 2012
Summary
Achieving a healthy weight in pregnancy is crucial. Midwives can educate overweight or obese pregnant women about risks and promote healthy lifestyle choices to prevent excessive weight gain.
Area of Science:
- Obstetrics and Gynecology
- Maternal Health
- Public Health
Background:
- Increasing prevalence of overweight and obesity in pregnant women.
- Obesity during pregnancy poses significant health risks to both mother and child.
- Potential for increased labor and delivery complications in obese pregnancies.
Purpose of the Study:
- To highlight the growing issue of maternal obesity.
- To inform about the associated health risks for pregnant women and neonates.
- To emphasize the role of midwives in managing maternal weight.
Main Methods:
- Observational analysis of current trends in maternal weight.
- Review of literature on risks associated with obesity in pregnancy.
- Assessment of the midwifery role in antenatal care and lifestyle guidance.
Main Results:
- Midwives are encountering a rising number of pregnant individuals who are overweight or obese.
- Obese pregnant women face elevated risks for adverse maternal and fetal outcomes.
- Higher likelihood of labor complications is observed in obese pregnancies.
Conclusions:
- Midwives are pivotal in educating pregnant women about obesity-related risks.
- Guidance on healthy diet and lifestyle is essential during pregnancy.
- Intervention by midwives can help mitigate excessive gestational weight gain.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:26Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...